News
Featured
The National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) has issued a $30.8 million grant to the Preclinical Design and Clinical Translation of TB Regimens (PreDiCTR) consortium, a new consortium co-led by investigators from Weill Cornell Medicine; the University of California, San Francisco; Johns Hopkins Medicine; and Vanderbilt University Medical Center. The grant, awarded in March 2024, aids the PreDicTR consortium with aims to accelerate the...
News
10 May 2010
Dr. Michele Miller, Chief Veterinary Officer and Director of the Center for Conservation Medicine at the Palm Beach Zoo When we think of infectious diseases, such as HIV or Tuberculosis , we usually consider them to be a human problem – there are rarely reports of disease in animals, unless it...
9 May 2010
TBVI The University of Zaragoza (Spain), together with TuBerculosis Vaccine Initiative (TBVI) and the Spanish Fundación Ramón Areces, presents an international symposium: “Research and Development of new Tuberculosis Vaccines”. This symposium will be held on 3 and 4 June in Zaragoza, Spain. During...
5 May 2010
Dr. Joel S. Freundlich Dr. Joel S. Freundlich attended Cornell University as a McMullen scholar and an Exxon scholar, attaining his B.S. degree with Distinction in Chemical Engineering in 1991 and his M. Eng. degree in Chemical Engineering in 1992. He received his Ph.D. degree in 1996 in Organic...
4 May 2010
Stop TB Partnership The Stop TB Partnership’s TB REACH initiative today announced the recipients of its first wave of grants to organizations that will engage in innovative approaches to increasing detection of tuberculosis (TB). Thirty applicants from 19 countries will together receive US$ 18.4...
3 May 2010
isoniazid structure Over the last month, a few reports about new positive TB cases have surfaced from FL, involving students at a couple of high schools and at a college. Information was not made available as to how the original infected TB individuals contracted TB. Furthermore, it is not clear...
2 May 2010
New research to speed TB drugs to those who need it most New York and Bangalore, India, May 3, 2010 The TB Alliance and AstraZeneca announced today at the 2010 BIO International Convention that they have entered into a research collaboration agreement to accelerate the discovery, development and...
29 Apr 2010
We first read this post at FierceBiotech.com . New drugs are needed to combat MDR-TB HAYWARD, Calif. and SHANGHAI, April 6 /PRNewswire/ — MicuRx Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development of antibiotics to treat drug-resistant bacteria, and Cumencor...
28 Apr 2010
Derived from the works of Paul-Henri Lambert, Tony Hawkridge, Willem A. Hanekom Clinics in Chest Medicine, 2009, vol 3. (4) pp. 811-26 TB patients awaiting treatment in Dhaka, Bangladesh photo: Jad Davenport Only one vaccine against tuberculosis (TB) now exists, bacille Calmette Guérin (BCG) ,...
26 Apr 2010
How much does the nose know about TB? In a post a few weeks ago , we highlighted HeroRats , African-pouch rats, and their use for TB diagnoses. As described in that article, these rats are trained to distinguish positive TB samples verses negative TB samples presumably due to the release of...
26 Apr 2010
This post originally appeared at http://www.news25.us/Global/story.asp?S=12380174 Purdue Chao Center Purdue drug maker closing its doors after 5 years Associated Press – April 27, 2010 4:14 AM ET WEST LAFAYETTE, Ind. (AP) – An Indiana drug maker that’s North America’s sole manufacturer of a...
25 Apr 2010
Open Forum 4: Key Issues in TB Drug Development August 18-19, 2010 | Addis Ababa, Ethiopia REGISTER NOW FOR: Open Forum 4: Key Issues in TB Drug Development August 18-19, 2010 | Addis Ababa, Ethiopia International Conference to address regulatory challenges to TB drug development in Africa. Don’t...
25 Apr 2010
Stop TB Partnership The latest issue no.10 of Stop-TB News Monitor, for the period, 23-26 April 2010, is available online at: http://stoptb.citizen-news.org/2010/04/cns-stop-tb-news-monitor-23-26-april.html CNS Stop-TB News Monitor provides a snapshot of five major news pieces on tuberculosis (TB)...
21 Apr 2010
Dr. Denis Mitchison in the lab When you think of true pioneers in research and development for the treatment of infectious diseases, Dr. Dennis Mitchison is sure to come to mind. For more than half a century, Dr. Mitchison has been dedicated to discovering new treatments for tuberculosis. Recently...
19 Apr 2010
This article originally appeared in Clinical Infectious Diseases 2010;50:S260–S266 © 2010 by the Infectious Diseases Society of America. All rights reserved. 1058-4838/2010/5010S3-0026$15.00 DOI: 10.1086/651500 Mark Harrington is Executive Director of Treatment Action Group Tuberculosis (TB) and...
19 Apr 2010
World Health Organization The World Health Organization’s Stop TB Department has published the fourth edition of Treatment of Tuberculosis: Guidelines. The guidelines contain a number of new recommendations, including a call to discontinue regimens based on just two months of rifampicin (2HRZE/6HE...